View DividendMEDYSSEYLtd 관리관리 기준 확인 0/4현재 CEO에 대한 정보가 충분하지 않습니다.주요 정보 최고 경영자n/a총 보상CEO 급여 비율n/aCEO 임기no dataCEO 소유권n/a경영진 평균 재임 기간데이터 없음이사회 평균 재임 기간데이터 없음최근 관리 업데이트MEDYSSEY Co.,Ltd, Annual General Meeting, Mar 23, 2021Feb 25모든 업데이트 표시Recent updatesMEDYSSEY Co.,Ltd, Annual General Meeting, Mar 23, 2021Feb 25New 90-day low: ₩7,650 Feb 22New 90-day low: ₩8,070 Feb 04New 90-day high: ₩9,930 Dec 22Dongwha Pharm.Co.,Ltd (KOSE:A000020) completed the acquisition of 53.3% stake in MEDYSSEY Co.,Ltd (XKON:A200580) from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim.Sep 26Dongwha Pharm.Co.,Ltd (KOSE:A000020) agreed to acquire 53.3% stake in MEDYSSEY Co.,Ltd (XKON:A200580) from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim for KRW 19.6 billion.Sep 25New 90-day high - ₩9,070 Sep 08New 90-day high - ₩6,760 Jul 24CEOMEDYSSEYLtd 에는 CEO가 없거나 그에 대한 데이터가 없습니다.View Ownership
Dongwha Pharm.Co.,Ltd (KOSE:A000020) completed the acquisition of 53.3% stake in MEDYSSEY Co.,Ltd (XKON:A200580) from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim.Sep 26
Dongwha Pharm.Co.,Ltd (KOSE:A000020) agreed to acquire 53.3% stake in MEDYSSEY Co.,Ltd (XKON:A200580) from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim for KRW 19.6 billion.Sep 25